tDCS Plus Varenicline for Smoking Cessation

NCT06798324 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Nicotine Dependence
Tobacco Smoking
Smoking Cessation
Nicotine Use Disorder
Tobacco Use Disorder
Substance Use Disorders

Interventions

DEVICE: Active Transcranial Direct Current Stimulation (tDCS)
DRUG: Varenicline 1mg BID
DEVICE: Sham Transcranial Direct Current Stimulation (tDCS)

Sponsor

Centre for Addiction and Mental Health

Collaborators

[object Object]